Extract from the Register of European Patents

EP About this file: EP2538948

EP2538948 - BIODEGRADABLE MATERIAL CONTAINING SILICON, FOR PRO-ANGIOGENETIC THERAPY [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  17.06.2016
Database last updated on 14.03.2026
Most recent event   Tooltip17.06.2016Application deemed to be withdrawnpublished on 20.07.2016  [2016/29]
Applicant(s)For all designated states
Bayer Innovation GmbH
Kaiser-Wilhelm-Allee 20
51373 Leverkusen / DE
[2013/01]
Inventor(s)01 / BAECKER, Iwer
Ernst-Gnoss-Str. 3
40219 Düsseldorf / DE
02 / SUSCHEK, Christoph
Neuenhofer Weg 11
52074 Aachen / DE
03 / ULRICH, Magda
Schermerhornerweg 1
NL-1463 PD Noordbeemster / NL
04 / BOEKEMA, Bouke
Van Merkensteijngaarde 9
NL-3981 XL Bunnik / NL
 [2013/01]
Representative(s)(deleted)
[N/P]
Former [N/P]BIP Patents
c/o Bayer Intellectual Property GmbH
Creative Campus Monheim
Alfred-Nobel-Strasse 10
DE-40789 Monheim / DE
Former [2013/01]BIP Patents
Creative Campus Monheim
Alfred-Nobel-Strasse 10
40789 Monheim / DE
Application number, filing date11706209.122.02.2011
WO2011EP52561
Priority number, dateDE2010100898124.02.2010         Original published format: DE102010008981
[2013/01]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report
No.:WO2011104215
Date:01.09.2011
Language:DE
[2011/35]
Type: A1 Application with search report 
No.:EP2538948
Date:02.01.2013
Language:DE
The application published by WIPO in one of the EPO official languages on 01.09.2011 takes the place of the publication of the European patent application.
[2013/01]
Search report(s)International search report - published on:EP01.09.2011
ClassificationIPC:A61K31/80, A61P9/00, A61P9/10, A61P17/02
[2013/01]
CPC:
A61K31/80 (EP,KR,US); C08G77/14 (KR,US); A61K31/765 (KR);
A61K33/00 (KR); A61P1/00 (EP); A61P1/02 (EP);
A61P1/04 (EP); A61P1/16 (EP); A61P1/18 (EP);
A61P11/00 (EP); A61P11/06 (EP); A61P11/08 (EP);
A61P13/00 (EP); A61P13/12 (EP); A61P15/10 (EP);
A61P17/00 (EP); A61P17/02 (EP); A61P17/04 (EP);
A61P17/06 (EP); A61P17/08 (EP); A61P17/14 (EP);
A61P19/00 (EP); A61P19/04 (EP); A61P19/08 (EP);
A61P19/10 (EP); A61P21/02 (EP); A61P25/00 (EP);
A61P25/14 (EP); A61P25/16 (EP); A61P25/18 (EP);
A61P25/28 (EP); A61P27/02 (EP); A61P27/06 (EP);
A61P29/00 (EP); A61P3/00 (EP); A61P3/06 (EP);
A61P3/10 (EP); A61P31/00 (EP); A61P37/00 (EP);
A61P37/06 (EP); A61P37/08 (EP); A61P7/02 (EP);
A61P7/06 (EP); A61P9/00 (EP); A61P9/08 (EP);
A61P9/10 (EP); A61P9/12 (EP); A61P9/14 (EP);
C04B35/6224 (EP,KR,US); C04B35/624 (EP,KR,US); C04B35/6263 (EP,KR,US);
C04B35/62635 (EP,KR,US); C04B35/62685 (EP,KR,US); C04B2235/441 (EP,KR,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2013/01]
TitleGerman:SILICIUMHALTIGES, BIOLOGISCH DEGRADIERBARES MATERIAL ZUR PRO-ANGIOGENETISCHEN THERAPIE[2013/01]
English:BIODEGRADABLE MATERIAL CONTAINING SILICON, FOR PRO-ANGIOGENETIC THERAPY[2013/01]
French:MATÉRIAU BIODÉGRADABLE CONTENANT DU SILICIUM POUR LA THÉRAPIE PRO-ANGIOGÉNÉTIQUE[2013/01]
Entry into regional phase24.09.2012National basic fee paid 
24.09.2012Designation fee(s) paid 
24.09.2012Examination fee paid 
Examination procedure24.09.2012Examination requested  [2013/01]
15.04.2013Amendment by applicant (claims and/or description)
29.07.2014Despatch of a communication from the examining division (Time limit: M06)
13.01.2015Reply to a communication from the examining division
06.10.2015Despatch of a communication from the examining division (Time limit: M04)
17.02.2016Application deemed to be withdrawn, date of legal effect  [2016/29]
16.03.2016Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2016/29]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  29.07.2014
Fees paidRenewal fee
28.02.2013Renewal fee patent year 03
12.02.2014Renewal fee patent year 04
26.02.2015Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
29.02.201606   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]   KANG YOUNG-MI ET AL: "Evaluations of osteogenic and osteoconductive properties of a non-woven silica gel fabric made by the electrospinning method.", ACTA BIOMATERIALIA JAN 2009 LNKD- PUBMED:18676190, vol. 5, no. 1, January 2009 (2009-01-01), pages 462 - 469, XP002630968, ISSN: 1878-7568

DOI:   http://dx.doi.org/10.1016/j.actbio.2008.07.004
by applicant  "Remington's Pharmaceutical Science", 1980, MACK PUBLISHING COMPANY
   MIDDELKOOP E ET AL.: "Porcine wound models for skin substitution and bum treatment", BIOMATERIALS, vol. 25, no. 9, April 2004 (2004-04-01), pages 1559 - 67, XP004481688, DOI: doi:10.1016/S0142-9612(03)00502-7

DOI:   http://dx.doi.org/10.1016/S0142-9612(03)00502-7
   ULRICH MM ET AL.: "Expression profile ofproteins involved in scar formation in the healing process of full-thickness excisional wounds in the porcine model", WOUND REPAIR REGEN., vol. 15, no. 4, July 2007 (2007-07-01), pages 482 - 90
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.